Thrombogenicity

IUPAC definition

Property of a material (or substance) that induces and/or promotes
the formation of a thrombus.

Thrombogenicity refers to the tendency of a material in contact with the blood to produce a thrombus, or clot. It not only refers to fixed thrombi but also to emboli, thrombi which have become detached and travel through the bloodstream. Thrombogenicity can also encompass events such as the activation of immune pathways and the complement system. All materials are considered to be thrombogenic with the exception of the normal state of endothelial cells which line blood vessels. Certain medical implants appear non-thrombogenic due to high flow rates of blood past the implant, but in reality all are thrombogenic to a degree. Various surface treatments are available to minimize these thrombogenic effects.

The process begins when blood proteins coat any artificial surface within seconds, changing shape in ways that trigger the body's clotting and immune systems to activate. Laboratory testing of thrombogenicity follows international standards but remains challenging because different research facilities use varying methods, making it difficult to compare results between studies. Efforts are now underway to create standardised reference materials and testing protocols that will allow more reliable prediction of how medical devices will perform in patients.